Cargando…
High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease
The exact cause of multiple sclerosis (MS) is unknown; however, it is considered to be an inflammatory disease of the central nervous system (CNS) triggered by a combination of both environmental and genetic factors. Vitamin D deficiency is also discussed as a possible disease-promoting factor in MS...
Autores principales: | Häusler, Darius, Torke, Sebastian, Weber, Martin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053380/ https://www.ncbi.nlm.nih.gov/pubmed/32161591 http://dx.doi.org/10.3389/fimmu.2020.00301 |
Ejemplares similares
-
Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough
por: Häusler, Darius, et al.
Publicado: (2019) -
Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease
por: Torke, Sebastian, et al.
Publicado: (2020) -
Central nervous system demyelinating diseases: glial cells at the hub of pathology
por: Coutinho Costa, Vinicius Gabriel, et al.
Publicado: (2023) -
Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases
por: Jiao, Li, et al.
Publicado: (2022) -
Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases
por: Ran, Zhou, et al.
Publicado: (2020)